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Baculovirus can transiently transduce primary human and rat hepatocytes, as well as a subset of stable cell
lines. To prolong transgene expression, we have developed new hybrid vectors which associate key elements
from adeno-associated virus (AAV) with the elevated transducing capacity of baculovirus. The hybrid vectors
contain a transgene cassette composed of the b-galactosidase (b-Gal) reporter gene and the hygromycin re-
sistance (Hygr) gene flanked by the AAV inverted terminal repeats (ITRs), which are necessary for AAV rep-
lication and integration in the host genome. Constructs were derived both with and without the AAV rep gene
under the p5 and p19 promoters cloned in different positions with respect to the baculovirus polyheidrin
promoter. A high-titer preparation of baculovirus-AAV (Bac-AAV) chimeric virus containing the ITR–Hygr–
b-Gal sequence was obtained with insect cells only when the rep gene was placed in an antisense orientation
to the polyheidrin promoter. Infection of 293 cells with Bac-AAV virus expressing the rep gene results in a 10-
to 50-fold increase in the number of Hygr stable cell clones. Additionally, rep expression determined the lo-
calization of the transgene cassette in the aavs1 site in approximately 41% of cases as detected by both
Southern blotting and fluorescent in situ hybridization analysis. Moreover, site-specific integration of the ITR-
flanked DNA was also detected by PCR amplification of the ITR-aavs1 junction in transduced human fibro-
blasts. These data indicate that Bac-AAV hybrid vectors can allow permanent, nontoxic gene delivery of DNA
constructs for ex vivo treatment of primary human cells.
Gene therapy is a rapidly emerging field that aims to treat a
variety of genetic or acquired diseases through the transfer of
functional genetic material into cells both in vitro and in vivo
(1, 30, 34). Critical to the success of gene therapy is the devel-
opment of safe and efficient gene transfer vehicles. To date,
various strategies have been developed for the transfer of ther-
apeutic genes which include viral and nonviral vectors. All of
these gene delivery systems, however, suffer from limitations in
their applicability and efficacy (49). Among the viral vectors
utilized for gene transfer protocols, adenovirus (Ad) vectors
deliver genes to a wide variety of cell types and tissues inde-
pendently of their proliferative state (9). However, the major
disadvantage of this type of vector is the instability of the genes
transferred into the target cell and the substantial pathology
that develops at the site of gene transfer. These problems can
be explained, at least in part, by a lack of integration of the
recombinant Ad genome and by the development of a strong
cellular immune response to the genetically corrected cells that
express low levels of viral proteins (13, 53). Despite some
improvements in reducing the immunogenicity of Ad vectors
(3, 50, 55), their use for long-term expression of the therapeu-
tic gene has yet to be fully assessed.
Retroviruses, the viral vectors currently most widely used,
offer the desirable feature of being able to insert a gene of
interest into the host genome, thus contributing to the stability
of the transduced gene (12). However, retroviruses have a
limited host range, and successful infection occurs only in mi-
totic cells, with the exception of the human immunodeficiency
virus (31). Additionally, retroviruses integrate randomly into
the host cell chromosome, thus raising some concern about the
potential activation of transcriptionally silent oncogenes and
the possible inactivation of tumor suppressor genes mediated
by insertional mutagenesis (43).
The adeno-associated virus (AAV) is also used for gene
delivery protocols. The lack of obvious pathogenic effects as-
sociated with AAV infection and the stability of the viral par-
ticle have elicited great interest in the use of AAV as a vector
in the field of gene therapy (10). Additionally, AAV is the only
known eukaryotic virus that preferentially integrates its DNA
into a defined region of the host cell genome located on chro-
mosome 19q13.3 (16, 28, 40). Although the mechanism of site-
specific integration is still unclear, two viral elements, namely,
the inverted terminal repeats (ITRs) and the Rep polypep-
tides, are required for targeting and inserting the viral DNA
into the integration locus aavs1 (42). The two 145-nucleotide
ITRs located at both ends of the viral genome are the minimal
cis-acting sequences required in the integration process. The
palindromic portions of the ITRs are capable of forming hair-
pin structures and serve as a self-priming origin for DNA
replication, as well as a site for binding of AAV Rep proteins
(20, 44, 48). The rep gene is transcribed from two promoters,
p5 and p19. Transcription from the p5 promoter generates
spliced and unspliced mRNAs which encode the Rep68 and
Rep78 proteins, respectively. Two smaller proteins, Rep40 and
Rep52, are encoded by spliced and unspliced mRNAs pro-
moted by the p19 promoter, respectively (45). These proteins
mediate replication and integration of the AAV genome, as
well as packaging into viral particles (7). In particular, Rep68
and Rep78 interact with the terminal sequences only if the
secondary structure of the termini is T shaped, a conformation
that is believed to exist in virion DNA (4, 20). Additionally,
these two large Rep polypeptides contain ATP-dependent he-
licase and strand-specific endonuclease activities which are
thought to be important both for viral DNA replication and
integration (21, 22). Furthermore, recent evidence has indi-
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cated that site-specific integration of an ITR-flanked DNA
segment requires expression of the Rep proteins (5, 37) and
that with only the expression of Rep78 or Rep68, highly effi-
cient integration into the aavs1 site is obtained (46).
The major limitation of AAV-based vectors resides in the
size constraint imposed by the inability of the mature AAV
particles to package DNA fragments larger than 5 kb. There-
fore, recombinant AAV vectors are generated by substituting
the endogenous genes with exogenous DNA, resulting in the
production of vectors that can no longer integrate in a site-
specific manner. In fact, although these viruses can persist both
in vitro and in vivo for prolonged periods of time, they do so
either as episomes or by integrating randomly into the host
chromosome (11, 14, 15, 24–27, 33, 38, 52).
Recently, the use of the Autographa californica multiple nu-
clear polyhedrosis virus as a vector for the delivery of genes
into mammalian cells has been reported (8, 19). Although
baculoviruses are normally utilized for the overexpression of
recombinant proteins in insect cells (35) or as biopesticides
(12), it was shown that A. californica multiple nuclear polyhy-
drosis virus can infect human hepatocytes, leading to an effi-
cient transient expression of reporter genes under the control
of an appropriate mammalian promoter (8, 19). In view of the
ease of preparation and large cloning capacity of baculovirus
(36), its use as vector for gene transfer holds great potential.
However, both the inability of baculovirus to transduce cells in
vivo (41) and the transient nature of the transferred DNA pose
some limitations for its use. To determine whether the persis-
tence of the baculovirus-transduced DNA can be prolonged,
we introduced the AAV rep gene and a transgene cassette
flanked by the AAV terminal repeats into a baculovirus back-
bone. We here show that a stable baculovirus-AAV (Bac-
AAV) hybrid vector can be produced in insect cells at a high
titer provided that the rep gene is cloned into an antisense
orientation with respect to the baculovirus polyhedrin pro-
moter. Additionally, we have determined that Bac-AAV infec-
tion of 293 cells results in highly efficient integration of the
transgene cassette in the aavs1 site. Lastly, we observed that
Bac-AAV can efficiently transduce human diploid fibroblasts,
which results in the site-specific integration of ITR-flanked
DNA. These findings extend the use of baculovirus as a vector
for gene therapy.
MATERIALS AND METHODS
Vector constructs. Recombinant baculoviruses were constructed by using the
transfer vector pFastBac1 (pFB1) (Gibco-BRL). A b-galactosidase (b-Gal)-ex-
pressing cassette was derived from plasmid pCMV-b (Clontech). The EcoRI-
HindIII fragment containing the cytomegalovirus (CMV) promoter, the b-Gal
gene, and the simian virus 40 (SV40) polyadenylation signal was inserted in the
modified sites of pFB1, generating plasmid pFB1Bac/CMV-b. To construct the
chimeric Bac-AAV vectors, a p5-Rep-poly(A) cassette (ClaI and SpeI) was sub-
cloned into the NspV and SpeI sites of pFB1, generating pFB1Rep-A.
A transgene cassette was assembled in plasmid pLitmus-28 (New England
Biolabs) by three cloning steps, generating pLit/AAV-Hyg-b-Gal, which contains
the following sequences: (i) the AAV ITRs derived from plasmid pSub201 (39)
as a PvuII fragment and subcloned in the blunted XbaI site of pLitmus-28; (ii) the
hygromycin resistance (Hygr) gene excised from plasmid pCEP-4 (Invitrogen) by
digestion with NruI and NotI and inserted between the ITRs in the filled-in XbaI
site; and (iii) the b-Gal cassette derived from plasmid CMV-b, which was intro-
duced between the ITRs by blunt-end cloning into the filled-in NotI and HindIII
sites.
Plasmid pLit/AAV-Hyg-b-Gal was digested with SpeI and AvrII, and the
6.5-kb fragment containing the transgene cassette was subcloned into the mod-
ified pFB1 vector (digested with XbaI and AvrII) or pFB1RepA to generate
Bac-ITR and Bac/ITR-RepA, respectively. Similarly, to generate plasmid Bac-
RepS, the p5-Rep fragment was inserted in the SfuI site of pFB1. Bac-ITR/RepS
was derived from Bac-Rep-S by introducing the transgene cassette as a AvrII-
SpeI fragment into the SpeI site.
Recombinant baculoviruses were produced according to the manufacturer’s
instructions (Gibco-BRL). Viruses were propagated in Sf9 insect cells according
to standard methods (36). Budded virus from insect cell culture medium was
filtered on a 0.22-mm (pore size) filter and concentrated by ultrafiltration in a 45
Ti rotor (30,000 rpm, 75 min). The viral pellet was resuspended in phosphate-
buffered saline (PBS), and the titers of the virus were determined by plaque assay
on Sf9 insect cells.
Cell culture. 293, Huh-7, and MRC-5 cells were maintained in Dulbecco
modified Eagle medium supplemented with 10% fetal calf serum, 2 mM glu-
tamine, 100 U of penicillin per ml, and 100 mg of streptomycin per ml. Cells were
grown in 10-cm-diameter dishes (Falcon) at 37°C in 5% CO2. Stock cells were
routinely passaged every 3 days by treatment with trypsin (0.05%) and EDTA
(0.53 mM) and then replated at cell densities appropriate for exponential growth.
To isolate stable cell clones, the infected cells from a single 6-cm-diameter
plate were plated at a density of 2 3 104 cells per plate in 10 plates containing
selection medium (Dulbecco modified Eagle medium, 10% fetal calf serum, and
300 mg of hygromycin per ml). Hygromycin-resistant (Hygr) clones were iso-
lated after 10 days of selection and then expanded and processed for genomic
DNA extraction, Southern blotting, and fluorescence in situ hybridization
(FISH) analysis. Assays for b-Gal activity were carried out using the b-Gal
enzyme assay system (Promega) as described by the manufacturer. b-Gal was
detected histochemically in cells fixed with 0.5% glutaraldehyde solution in PBS
and by incubation for 4 h with staining solution (4 mM K4[Fe(CN)6], 4 mM
K3[Fe(CN)6], 40 mM MgCl2, 0.4-mg/ml X-Gal [5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside] in PBS).
Western blot analysis. The expression of AAV Rep proteins was evaluated by
Western blotting with a polyclonal antibody which recognizes all four Rep iso-
forms (47). A total of 2 3 106 Sf9 cells were infected at a multiplicity of infection
(MOI) of 10, and 72 h later cells were collected, washed in PBS, and lysed by
freezing and thawing three times in lysis buffer [10 mM HEPES buffer [pH 8.0],
0.6 M NaCl]. Portions (200 mg) of proteins of each sample were separated by
sodium dodecyl sulfate (SDS)–12.5% polyacrylamide gel electrophoresis and
then transferred onto a nitrocellulose membrane. The nitrocellulose membrane
was immersed in 1% skimmed milk in Tris-buffered saline (20 mM Tris-HCl, 500
mM NaCl [pH 7.5]) (blocking buffer) for 20 min at room temperature. The
anti-Rep polyclonal antiserum diluted in blocking buffer was applied to the
nitrocellulose membrane and incubated for 1 h at room temperature. The mem-
brane was then washed repeatedly with blocking buffer. The bands were visual-
ized with ECL reagents according to the manufacturer’s instructions (Amer-
sham).
Southern blot analysis. Baculovirus genomic DNA was prepared from 1-ml
portions of the third viral passage according to standard protocols (35). One
microgram of viral DNA was digested with EcoRV, which releases two fragments
of 4 and 10 kb. After electrophoresis in 1% agarose gel, the digested fragments
were transferred onto a nylon membrane (Hybond N1), processed according to
the manufacturer’s instructions, and hybridized overnight at 65°C in Church
buffer (7% SDS, 0.25 M NaPi [pH 7.2], 1 mM EDTA [pH 8.0], bovine serum
albumin [0.1 g/ml]) with random primed 32P-labeled probes. The following
probes were used: for the gentamicin gene a 1.3-kb EcoRV-BamHI fragment
derived from the plasmid pFastBac1 and for the transgene cassette a 6.5-kb
AvrII-SpeI fragment derived from plasmid pLit/AAV-Hyg-b-Gal.
To determine site-specific integration of the ITR-DNA fragment, genomic
DNA was prepared as previously described (37) and processed as described
above. Filters were first hybridized with a probe specific for the transgene cas-
sette; the hybridized probe was then removed by boiling the filters in 0.23 SSC
(13 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and 1% SDS for 10 min,
and the same filters were then hybridized to a probe covering nucleotides 1 to
3,525 of aavs1.
FISH. A 6.5-kb DNA fragment corresponding to the transgene cassette and an
80-kb aavs1 DNA fragment isolated by screening a genomic DNA library were
labeled by using the Nick Translation Kit (Boehringer Mannheim) according to
the manufacturer’s instructions and used as probes in chromosome analysis.
The chromosome spreads from selected clones were prepared according to
typical cytogenetic techniques (29). Cytogenetic preparations were pretreated
with pepsin solution and dehydrated by washing with cold 70, 90, and 100%
ethanol. The preparations were then denatured with a 50% formamide solution.
For each sample, 200 ng of probe, 2 mg of human Cot-1 DNA, and 9 mg of
sonicated salmon sperm DNA were precipitated and resuspended in hybridiza-
tion buffer (50% formamide, 23 SSC, 1% bovine serum albumin, and 10% dex-
tran sulfate). Probes were denatured for 8 min at 80°C and subsequently incu-
bated for 10 min at 37°C to allow preannealing of repeated sequences. Finally,
the hybridization solution was placed on the samples, covered with coverslips,
and incubated overnight at 37°C in a moist chamber. The samples were then
washed three times in 50% formamide and three times in 23 SSC at 42°C.
Visualization of the biotin-labeled probe was carried out by repeated incubations
with Cy3-avidin (Amersham), biotinylated anti-avidin D (Vector Laboratories),
and again with Cy3-avidin. The digoxigenin-labeled probe was detected by using
mouse anti-digoxigenin antibody, digoxigenin-labeled anti-mouse antibody, and
fluorescein isothiocyanate (FITC)-labeled anti-digoxigenin antibody (Boehringer
Mannheim). Alternatively, FITC-avidin (Vector Laboratories) and rhodamine-
labeled antidigoxigenin (Boehringer Mannheim) were used. After immunode-
tection, slides were counterstained with 200 ng of 49,6-diamidino-2-phenylindole
(DAPI). UV excitation was used to locate metaphases, and photographic images
were taken with a charge-coupled-device (CCD) camera (Photometrics) with
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green (FITC) or blue-violet (Cy3 or rhodamine) illumination. Images were
processed with Adobe Photoshop on an Apple Quadra computer.
PCR amplification of the ITR-aavs1 junction. Integration of ITR-flanked
DNA in the aavs1 site was determined by PCR by using nested primer pairs that
flank the AAV-chromosome junction as previously described (17, 37): primers
16s (AAV), 59-GTAGCATGGCGGGTTAATCA, and 15a (aavs1), 59-GCGCG
CATAAGCCAGTAGAGC, were used in the first round of PCR amplification
with 0.5 mg of genomic DNA as the substrate. After an initial incubation for 4
min at 94°C, the reaction mixture was subjected to 30 cycles of PCR amplification
for 1 min at 94°C, 1 min at 55°C, and 2 min at 72°C. One percent of the
amplification product was diluted into a new reaction mixture containing a set of
nested primers with the following sequences: 17s (AAV), 59-TTAACTACAAG
GAACCCCTA, and Cr2 (aavs1), 59-ACAATGGCCAGGGCCAGGCAG. The
PCR parameters were the same as for the first amplification. For molecular
cloning of the amplified junction fragments, the product of the second round of
amplification was purified on a 1% agarose gel and subcloned by blunt end
ligation into plasmid pZERO-2.1 (Invitrogen). Sequencing was performed by
standard chain termination protocols.
RESULTS
Construction of hybrid Bac-AAV vectors. To take advantage
of the ease of manipulation of baculovirus and of the unique
ability of AAV virus to preferentially integrate its viral DNA
into a defined region of human chromosome 19, we construct-
ed a series of baculovirus vectors carrying AAV components
known to be required for excision and integration of the AAV
genome in the aavs1 site in human cells. Figure 1 shows the
vectors used in this study. To determine the transduction effi-
ciency of the recombinant baculoviruses and to establish stable
cell clones from the infected cells, the b-Gal and Hygr genes
were inserted between the AAV ITRs and cloned downstream
of the baculovirus polyheidrin promoter (pPolh) (Bac-ITR).
Additionally, the AAV Rep gene under the control of its own
promoters p5 and p19 was cloned outside of the ITRs either in
the sense orientation (Bac-ITR/RepS) or in the antisense ori-
entation (Bac-ITR/RepA) with respect to the pPolh promoter.
Lastly, baculoviruses carrying the CMV–b-Gal expression cas-
sette (Bac–b-Gal) or the rep gene (Bac-Rep) were also con-
structed as controls for transduction efficiency and Rep expres-
sion. Viruses were produced at high titers (ranging from 1 3
109 to 9 3 109 PFU/ml) and used to infect mammalian cells.
In an initial functional analysis of the transducing capacity of
the recombinant baculovirus vectors, we observed that the
transient b-Gal gene expression in infected strain 293 cells
generally increased as a function of the MOI, a finding in
agreement with published data (references 8 and 18 and data
not shown). To determine whether the transducing capacity of
baculovirus could be extended to other cell types, baculovirus
transduction efficiency in human diploid fibroblast MRC-5 was
compared to that observed in the human hepatoma cell line
Huh-7. The hepatoma cell line has been shown to be extremely
susceptible to baculovirus transduction (19). Figure 2 shows
b-Gal gene expression detected in MRC-5 and Huh-7 cells
infected with Bac–b-Gal at different MOIs (25, 50, and 100) at
48 h postinfection. These two cell lines showed comparable
levels of b-Gal, thus indicating that these cells are equally
susceptible to baculovirus infection; similar results were ob-
tained upon infection of primary rat fibroblasts (data not
shown). These results indicate that baculovirus transducing
capacity can also be extended to primary cultures that are not
necessarily of hepatic origin.
Stability of recombinant Bac-AAV genomes. When the trans-
duction efficiencies of Bac-ITR, Bac-ITR/RepA, and Bac-ITR/
RepS were compared by infecting 293 cells at MOIs of 50 and
100, we found that the Bac-ITR virus efficiency was signifi-
cantly higher than that of Bac-ITR/RepA. However, both vi-
ruses displayed a similar increase in b-Gal gene expression as
a function of MOI. In contrast, very little, if any, b-Gal gene
expression could be detected upon infection of 293 cells with
Bac-ITR/RepS (Fig. 3).
To determine whether the Bac-ITR/RepS genome had un-
dergone partial rearrangement during virus amplification, thus
explaining its low transducing efficiency, we examined the in-
tegrity of Bac-AAV genomes by Southern blot analysis. Geno-
mic DNA was digested with EcoRV and resolved on an aga-
rose gel. EcoRV was chosen because it cleaves once within the
ITR-flanked transgene sequence and once within the gentami-
cin gene, releasing three fragments of 10, 4, and 1.3 kb. Figure
4 shows the viral DNA genomic blots hybridized with a probe
specific for the transgene cassette (Fig. 4A) and for the gen-
tamicin gene (Fig. 4B). The gentamicin gene is present in all
virus genomes and therefore was used as an internal control.
Quantification of transgene probe hybridization, normalized
for that of gentamicin, indicated that the hybridization signal
of Bac-ITR/RepA was 11.4-fold higher than that of Bac-ITR/
RepS (Fig. 4A, compare lane 3 to lane 1), whereas no signif-
FIG. 1. Schematic representation of the recombinant baculoviruses used in
this study. Baculovirus transfer plasmids were derived from pFastBac1 as de-
scribed in Materials and Methods. The E. coli b-Gal gene, the Hygr gene
(HYGRO), the rep gene (Rep), and the AAV ITRs are indicated. The expres-
sion of the b-Gal and Hygr genes is driven by the CMV and TK promoters,
respectively. The p5 and p19 promoters regulate expression of the rep gene.
Transcription initiation sites of the baculovirus polyhedrin promoter (pPolh) and
of the p5 and p19 promoters are indicated by an arrow. Relevant EcoRV
restriction sites are indicated with an E.
FIG. 2. Baculovirus-mediated expression of b-Gal in MRC-5 and Huh-7
cells. Cells (105) were plated and infected with Bac–b-Gal at the MOI indicated.
At 48 h postinfection total cell extracts were prepared, normalized for protein
content, and assayed for b-Gal activity. Each column reflects the average of
results of two independent assays, with the error bars representing the standard
deviations.
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icant difference was observed between Bac-ITR/RepA and
Bac-ITR (Fig. 4A, compare lane 3 to lane 2). Thus, these data
suggest that the low transduction efficiency of Bac-ITR/RepS
may be ascribed to the loss or rearrangement of the ITR-
flanked transgene cassette during the process of baculovirus
amplification.
The three recombinant viral genomes produced in Esche-
richia coli did not show any detectable rearrangement (data not
shown); therefore, we hypothesized that loss of the b-Gal and
Hygr expression cassette occurred during Bac-ITR/RepS am-
plification in insect cells. Specifically, in view of the role of the
Rep polypeptides in promoting the selective excision and am-
plification of the ITR-flanked DNA (44, 48), we speculated
that loss of the transgene cassette could be associated with the
expression of Rep isoforms in Sf9 cells. To verify this hypoth-
esis, insect cells were infected with the Bac-AAV vectors and
the Rep expression pattern was assessed by Western blotting.
As shown in Fig. 4C, Rep78, Rep68, and Rep52 could be
clearly detected in Bac-Rep infected cells (Fig. 4C, lane 1),
whereas no Rep polypeptides could be detected in Bac-ITR
cell lysates (Fig. 4C, lane 2). Interestingly, the expression level
of Rep polypeptides differed between Bac-ITR/RepS and Bac-
ITR/RepA cell lysates (Fig. 4C, compare lanes 2 to lanes 4).
rep gene expression was lower in cells infected with the Bac-
AAV carrying the rep gene in the antisense orientation with
respect to pPolh than in the corresponding virus carrying the
rep gene in a sense orientation. Thus, in agreement with the
Southern blot analysis of genomic DNA, these results suggest
that the ITR-flanked cassette is destabilized in Bac-AAV virus
genome when Rep proteins are expressed above a certain
threshold.
Bac-AAV infection of 293 cells. Recent studies have shown
that transfection of strain 293 cells with a plasmid carrying the
rep gene and a green fluorescence protein expression cassette
inserted between the AAV terminal repeats results in a highly
efficient integration of the ITR-flanked DNA (5, 37, 46). On
the basis of this observation we wanted to determine whether
the delivery of AAV components mediated by baculovirus can
establish more stable cell clones. To this end, 293 cells were
infected with Bac–b-Gal, Bac-ITR/RepA, and Bac-ITR vec-
tors, and the transduction efficiencies of these viruses and the
stable integration of the ITR-flanked DNA were compared by
measuring b-Gal expression and the production of Hygr clones.
Figure 5A shows the reporter activity measured in infected
cells cultured in the absence of selection as a function of time
(up to 14 days postinfection). Although the transduction effi-
ciencies determined at day 1 postinfection were similar with all
three vectors (data not shown), the residual b-Gal activity at
day 14 postinfection was much higher in the Bac-ITR/RepA-
infected cells than in those infected with either Bac-ITR, which
does not contain the rep gene, or Bac–b-Gal, which contains
only the b-Gal expression cassette.
To assess the influence of the AAV components on the
frequency of integration events, a sample of cells infected with
either Bac-ITR or Bac-ITR/RepA was collected at day 4 post-
infection and plated in hygromycin selection medium. As shown
in Fig. 5B, infection of strain 293 cells with Bac-ITR/RepA re-
sulted in a significantly higher number of stable cell clones than
did infection of cells with Bac-ITR. The increase in the number
of Hygr clones ranged in several experiments from 10- to 50-
fold (data not shown).
Five hundred Hygr clones were obtained by plating 20,000
cells infected with Bac-ITR/RepA. Based on the cloning effi-
ciency of the 293 cells (50%) and on the percentage of the cells
transduced by Bac-ITR/RepA (50%), we estimate that approx-
imately 10% of the transduced cells carrying the Hygr gene
integrated into the host genome. In addition, the majority of
the Hygr clones (.90%) expressed b-Gal genes (as determined
by histochemical staining of the infected cells), suggesting that
the entire ITR-flanked transgene cassette had been inserted
into the host chromosome. These results indicate that under
both selective and nonselective conditions, baculovirus delivery
of the rep gene allows a very efficient transduction of ITR-
FIG. 4. Stability of recombinant Bac-AAV viruses. (A) Southern blot anal-
ysis of baculovirus genomes. One microgram of viral DNA prepared from the
third viral passage was digested with EcoRV, fractionated on 1% agarose gel,
transferred to a nylon membrane, and then hybridized with a probe specific for
the transgene sequence. The expected bands of 4 and 10 kb are indicated by an
arrow. (B) The same filter was stripped and hybridized with a probe specific for
the gentamicin gene, which recognizes a 1.3-kb band. The intensity of the bands
(indicated by arrows) in both panels A and B were quantified with a phosphor-
imager according to the manufacturer’s instructions. (C) Western blot detection
of Rep isoforms expressed in Sf9 cells infected with different baculoviruses at an
MOI of 10. At 2 days postinfection the total cell extracts were analyzed for the
presence of Rep proteins. Rep78, Rep68, and Rep52 are indicated by an arrow.
FIG. 3. Baculovirus-mediated expression of b-Gal activity in strain 293 cells
infected with different constructs (Bac-ITR, Bac-ITR/RepS, and Bac-ITR/RepA) at
MOIs of 50 and 100. Infection of 293 cells, preparation of cell extracts, and the
b-Gal assay were carried out as indicated in Materials and Methods.
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flanked cassette, probably by mediating its insertion into the
human genome.
Site-specific integration of ITR-flanked DNA. It has been
shown that the rep gene mediates site-specific integration of
ITR-flanked DNA fragment into the aavs1 site (5, 37, 46). To
verify the efficiency of site-specific integration mediated by the
Bac-AAV vectors, Hygr clones from strain 293 cells infected
with Bac-ITR/RepA and Bac-ITR were isolated and expanded
and total genomic DNA was then subjected to Southern blot
analysis. The rearrangement of the aavs1 site resulting from
the integration of the ITR-flanked transgene cassette was as-
sessed by using aavs1- and Hyg–b-Gal-specific probes. Site-
specific integration of the transduced transgene cassette was
scored when the aavs1-specific probe recognized additional
bands that were absent in mock-infected cells and when the
same additional bands were also detected by the transgene
probe.
The analysis of some of the strain 293 clones derived from
infection with Bac-ITR is shown in Fig. 6. The genomic DNA
extracted from nine independent clones was digested with
ApaI and analyzed by Southern blotting. ApaI was chosen be-
cause it cleaves once in the aavs1 sequence but does not cleave
within the transgene. Thus, the insertion of the transduced
DNA into the aavs1 site should be easily detectable by the
altered pattern of one of the aavs1-derived restriction frag-
ments. The aavs1-specific probe recognizes two bands of ap-
proximately 2.5 and 2.8 kb (Fig. 6A, lanes 2 to 10). Addition-
ally, the hybridization pattern of the infected clone DNA is
identical to that of the mock-infected cell DNA (Fig. 6A, lane
1). Single or double bands ranging in size from 8 to 20 kb were
detected in selected DNA clones when the same genomic blot
was hybridized with a probe specific for the transgene cassette.
Thus, in all of the clones analyzed no obvious rearrangement
of the aavs1 site could be ascribed to the infection of Bac-ITR,
indicating that the integration of the transgene occurred at
sites other than aavs1.
Figure 7 shows the hybridization pattern obtained with the
clones derived from the Bac-ITR/RepA-infected cells. In 13 of
22 clones (59%) (Fig. 7A, clones C1, D1, B1, H1, G4, E1, A2,
H3, F3, H4, C3, D2, and D4), rearrangement of the aavs1
region was apparent. The same genomic blot was then hybrid-
ized with a transgene probe to ascertain the presence of the
transgene sequences within the rearranged aavs1 bands. In 8 of
13 clones (61%) (Fig. 7B, clones C1, B1, H1, G4, E1, C3, D2,
and D4), bands were detected which hybridized to the trans-
gene probe matching those obtained with aavs1 probe (shown
with an arrow), indicating that the transgene was indeed in-
serted in the aavs1 site. Thus, site-specific integration occurred
in 8 of 22 clones (36%) analyzed. Additional transgene bands
detected only with the transgene probe were present in half the
clones analyzed. These bands might be due to rearrangements
in the aavs1 region flanking the transgene sequences (40) or to
multiple insertions at sites other than aavs1.
To confirm the site-specific integration of the transduced
ITR-DNA cassette and to differentiate between single and
multiple integration events into different sites, FISH analysis of
metaphase spreads was performed on infected strain 293 cells
by using the aavs1- and transgene-specific probes. Metaphases
were scored as positive only if both probes were colocalized on
both sister chromatids of a given chromosome.
At 10 days after infection with Bac-ITR/RepA, 400 Hygr
clones were pooled and analyzed by FISH. The transgene
probe colocalized with the aavs1 probe in 10 of the 24 (41%)
metaphases analyzed (Fig. 8B), whereas in the remaining met-
aphases the transgene probe was located on different chromo-
somes that were not detected by the aavs1 probe (Fig. 8A). The
aavs1 probe annealed to three or four chromosomes 19 in most
FIG. 5. (A) Time course detection of b-Gal activity in strain 293 cells in-
fected with different baculovirus vectors (CMV–b-Gal, Bac-ITR, and Bac-ITR/
RepA) at an MOI of 100. Reporter activities were measured at days 4, 7, and 14
postinfection on a subset of the cell passages. b-Gal activities detected at days 7
and 14 are expressed as percentages of the activity detected at day 4, which is
arbitrarily considered to be 100%. (B) Hygr clones derived from Bac-ITR/RepA-
or Bac-ITR-infected 293 cells. From the experiment described in panel A, cell
aliquots were collected at day 4 postinfection and plated in hygromycin-selective
medium. At 14 days postinfection the clones were fixed and stained with 10%
Giemsa and counted under a microscope. Only clones containing more than 50
cells were scored.
FIG. 6. Southern blot analysis of strain 293 Hygr clones derived from Bac-
ITR infection. Ten micrograms of genomic DNA from each clone was digested
with ApaI, fractionated on 1% agarose gel, and transferred to a nylon membrane.
(A) Hybridization to an aavs1 probe. The two detected bands of roughly 2.5 and
2.8 kb correspond to the aavs1 preintegration site. (B) Same membrane after
rehybridization to a transgene-specific probe. The positions of molecular size
standards (in kilobases) are indicated.
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of metaphases analyzed, in agreement with the polyploid na-
ture of this cell line. No hybridization of the transgene probe
was detected on mock-infected cells (data not shown). Al-
though FISH analysis is not strictly quantitative, the site-spe-
cific integration frequency of 41% established by FISH analysis
of pooled cell clones is in good agreement with the integration
frequency of 36% derived from Southern blot analysis of single
clones. The colocalization of the transgene and aavs1 probes
was also observed upon FISH analysis of metaphases derived
from the individual clones that had been previously character-
ized by Southern blotting (data not shown).
Analysis of ITR-aavs1 junctions. To precisely identify the
integration site of the transgene cassette, 293 and MRC-5 cells
were infected with Bac-ITR/RepA and the genomic DNA was
extracted and subjected to amplification of the ITR-aavs1 junc-
tion. For this purpose, two sets of nested primers specific for
the AAV terminal repeat and chromosome 19 were used (17,
37). As a control, genomic DNA from cells infected with Bac-
ITR was also analyzed. As shown in Fig. 9A, specific DNA
bands were amplified from MRC-5 cells infected with Bac-
ITR/RepA at MOIs of 100 and 500. The size difference of the
DNA bands probably reflects the different junction species
amplified from the population of transduced cells. In contrast,
no specific product was detected with mock- or Bac-ITR-in-
fected cells. A similar protocol was utilized to amplify the
ITR-aavs1 junction from Bac-ITR/RepA-infected 293 cells.
The amplified DNA bands were cloned and sequenced, and
the sequence data is shown in Fig. 9B. In MRC-5 cells, the
insertion of the ITR-flanked transgene cassette was mapped at
nucleotide 1111 of aavs1, where a short homology between the
AAV ITR and aavs1 can be identified in the GCC triplet. A
deletion of 43 and 83 bases within the ITR sequence was also
identified. Similarly, the ITR-aavs1 junctions amplified from
pooled Hygr 293 clones indicated that the insertion of the
FIG. 7. Southern blot analysis of strain 293 Hygr clones derived from Bac-
ITR/RepA infection. Conditions of infection and DNA analysis were as de-
scribed in Fig. 6. (A) Hybridization to aavs1 probe. (B) Same membrane hybrid-
ized to transgene probe. The upshifted bands that are annealed to both probes
are considered to be indicative of site-specific integration and are indicated with
arrows. The positions of the molecular size standards (in kilobases) are indicated.
FIG. 8. In situ hybridization of metaphase chromosomes from a pool of 400
strain 293 Hygr clones derived from Bac-ITR/RepA infection. Chromosome
preparations were hybridized with a Hyg–b-Gal-specific (in red) or aavs1-specific
(in yellow) probe as described in Materials and Methods. (A) The transgene is
integrated into a chromosome other than chromosome 19. (B) Colocalization of
the transgene and of the aavs1 probe.
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transgene cassette had occurred at nucleotides 1012, 1080, and
1096 of aavs1. Interestingly, in clone 293-2 an insertion of three
nucleotides was detected at the junction between the ITR and
aavs1. A larger insert of 101 nucleotides was identified in clone
293-1. This insert is partially homologous to sequence X62488
deposited in the GenBank database by Samulsky and cowork-
ers and is derived from amplification of the ITR-aavs1 junction
from AAV-infected cells (40). Taken together, these results
indicate that, analogous to what has been observed following
AAV infection and in transfection of AAV-derived plasmids
(5, 37, 42, 46), baculovirus-mediated transduction of human
cells results in the integration of the ITR-flanked DNA cas-
sette in a specific region of the aavs1 site.
DISCUSSION
In this study, we described the construction of a novel hybrid
virus which combines the remarkable transducing efficiency of
baculovirus with the unique property of site-specific integra-
tion characteristic of AAV. The Bac-AAV vector constructed
displays the following properties: genome stability upon virus
amplification, highly efficient transduction of primary cells, and
targeted integration of the ITR-flanked DNA. Thus, this hy-
brid virus is ideal for the delivery of large DNA segments to
both culture and primary cell lines where the gene of interest
flanked by the AAV terminal repeats can be maintained and
expressed for an extended period of time.
The strategy implemented in the construction of the hybrid
Bac-AAV vector is based on the observation that baculovirus
readily infects hepatocytes without any apparent toxic effect on
the transduced cells (8, 19). Interestingly, baculovirus can in-
fect not only hepatic cells, but also other cell types such as the
human fibroblast cell strain MRC-5 (Fig. 2), human embryonic
kidney cells strain 293 (Fig. 3), HeLa cells (54), and primary rat
fibroblasts (data not shown). The efficiency of baculovirus
transduction of these cell types is quite high and reaches levels
comparable to those observed with hepatoma cell line Huh-7
(data not shown). Thus, although the mechanism of viral up-
take is not clear, these results indicate that the ability of bac-
ulovirus to express a reporter gene is quite general and can be
observed in a variety of cell types.
Rep polypeptides are expressed in Sf9 cells (Fig. 4), indicat-
ing that the p5 and p19 promoters that govern transcription of
the rep gene are also functional in insect cells. Rep proteins
inhibit the replication of a number of viruses, including SV40
(6), human immunodeficiency type 1 (2), bovine papillomavi-
rus type 1 (18), and Ad (51). Apparently, rep expression does
not interfere with baculovirus replication since hybrid Bac-
AAV viruses carrying the rep gene grow to titers comparable to
those of other recombinant baculoviruses (data not shown).
Interestingly, hybrid vectors carrying both the rep gene and the
ITR-flanked transgene cassette can be amplified only where
the rep gene is positioned in an antisense orientation with
respect to the pPolh promoter (Fig. 1 and 4). The reduction in
Rep protein expression in cells infected with Bac-ITR/RepA
may be explained, at least in part, by the transcription of
antisense Rep RNA mediated by the pPolh promoter, which is
known to be very active in these cells (36). The mechanism by
which the expression of Rep polypeptides may compromize the
stability of the Bac-AAV genome is not clear, but it can be
assumed that the excision of the ITR-flanked transgene cas-
sette is mediated by the expression of Rep polypeptides upon
baculovirus amplification in Sf9 cells. Although AAV replica-
tion requires Ad helper functions (7), it has been demonstrated
by transfection studies of AAV plasmids that overexpressed
Rep proteins can excise the ITR-flanked DNA, converting it
into monomer-sized replicative intermediate molecules even in
the absence of Ad functions (32). Thus, although we have not
assessed the functionality of Rep polypeptides in insect cells, a
similar event may have occurred in Sf9 cells infected with the
Bac-ITR/RepS, leading to disruption of the Bac-AAV genome
structure. The stability of the Bac-ITR/RepA may in turn be
explained by the reduced amount of Rep polypeptides which,
in the context of the Sf9 cells, may not have been sufficient to
mediate the excision of the ITR-flanked cassette.
The correlation between the level of rep gene expression and
the loss of the ITR-flanked DNA has important implications
for the construction of mammalian hybrid vectors carrying
FIG. 9. (A) PCR amplification of the ITR-aavs1 junction in baculovirus-infected strain 293 cells. Cells were infected at the indicated MOI and were collected 4 days
postinfection; total DNA was prepared and subjected to nested PCR amplification as described in Materials and Methods. Bands corresponding to primers and
amplified junctions are indicated. (B) ITR-aavs1 junction sequences from Bac-ITR/RepA-infected 293 and MRC-5 cells. Common bases at the ITR-aavs1 junction are
underlined. Sequences not belonging to ITR or aavs1 are in boldface. X62488 was identified in GenBank with a Blast search. Sequences are depicted in ITR, aavs1
order.
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both the rep gene and the ITR-flanked DNA. If these recom-
binant vectors are amplified in mammalian cells, the efficiency
of rep-mediated excision of the ITR cassette may jeopardize
the integrity of the genome structure of the recombinant virus.
Thus, the construction of chimeric vectors carrying these ge-
netic elements may require a tight control of rep gene expres-
sion. Interestingly, the construction of a hybrid herpesvirus-
AAV vector was recently reported (23). This vector prolongs
expression of the b-Gal reporter gene, albeit only for a few
days. The overall genomic structure of the hybrid virus was not
described, and thus it is entirely possible that, analogous to our
observations with Bac-ITR/RepS, the expression of the Rep
polypeptides may have caused partial loss of the ITR-flanked
cassette.
The prolonged b-Gal expression in the presence of the rep
gene (Fig. 5) reflects an increase in integration levels stimu-
lated by the Rep polypeptides, demonstrating the validity of
the Bac-AAV vector in ensuring prolonged persistence of the
transgene cassette. This conclusion is also supported by the
observation that the number of Hygr strain 293 clones obtained
with Bac-ITR/RepA infection is 10- to 50-fold higher than with
Bac-ITR alone (Fig. 5). A similar observation based on trans-
fection of 293 cells with plasmids carrying the rep gene has
been recently reported (5, 46). We do not know if the higher
transduction efficiency based on the expression of rep is re-
stricted to strain 293 cells and may be attributed to the E1A-
mediated induction of the p5 promoter or if the enhanced
integration is observable in other cell types. To this end, we are
currently examining the integration efficiency of Bac-AAV in
other cell types.
The fate of the ITR-flanked transgene in selected clones was
assessed by Southern blot analysis, FISH, and PCR amplifica-
tion of the ITR-aavs1 junction. In agreement with several re-
ports (5, 37, 37a, 46), targeting of the ITR-flanked DNA to
aavs1 is dependent on the expression of the rep gene since no
integration of the ITR-transgene in chromosome 19 was de-
tected upon infection of the 293 cells with Bac-ITR (Fig. 6). In
contrast, Bac-ITR/RepA infection of 293 cells results in a 36 to
41% frequency of site-specific integration (Fig. 7 and 8). The
frequency of integration observed upon baculovirus infection
of 293 cells is comparable to that detected in these cells upon
infection with recombinant AAV virus or with the transfection
of AAV-derived plasmids (5, 37, 42, 46). However, in a study
of bronchial epithelial cells, in 94% of the cells containing
integrated wild-type AAV, the virus genome was mapped on
chromosome 19 by FISH (25). Additionally, approximately
70% of latently infected cell lines that were analyzed in an-
other survey were found to contain AAV inserted into aavs1
(42). Thus, the integration efficiency detected in other cell
types with wild-type AAV appears to be significantly greater
than that observed in 293 cells upon either plasmid transfec-
tion or Bac-AAV infection. The biological significance of this
difference in integration efficiency is not clear; however, it is
tempting to speculate that it may reflect differences in the
concentration of specific host factors that may contribute to
targeting to the aavs1 site of the AAV-derived DNA.
Southern blot analysis of the selected strain 293 clones re-
vealed the presence of several bands corresponding to rear-
ranged aavs1 sequences that can be accounted for by the in-
sertion of the transgene cassette (Fig. 7). Also, several bands
hybridized only by the aavs1 probe indicate that rearrangement
of the aavs1 as a consequence of rep expression may have taken
place, much as has been observed upon transfection of AAV-
derived plasmids and subsequent selection of neomycin-resis-
tant 293 clones (5). Interestingly, in half of the clones analyzed
the probe specific for the b-Gal–Hygr genes detected an addi-
tional band which varied in size. An additional band was also
detected in clones infected with Bac-ITR. Although this band
appears less intense, it probably represents a second integra-
tion event. In line with this hypothesis, FISH analysis revealed
the presence of second integration events in a minority of the
metaphases analyzed (Fig. 8).
The 6.5-kb transgene cassette inserted between the ITRs
contains the Hygr gene and the b-Gal gene that were coselect-
ed in the presence of hygromycin in almost all of the clones
analyzed (data not shown). Although this cassette is 2 kb long-
er than the wild-type virus genome, site-specific integration of
the ITR-flanked DNA was observed when the rep gene was
carried on the same virus (Fig. 7 and 8). We have not examined
the fine structure of the ITR-flanked DNA inserted into the
aavs1 site. However, the size of the bands hybridized by both
the transgene and aavs1 probes is consistent in most clones
with insertion of the full-length ITR-flanked transgene cas-
sette. This possibility is also supported by the observation that
both reporter genes are expressed in all clones and, most im-
portantly, in those clones where only one upshifted band is de-
tected. It is, however, possible that fine rearrangements at the
integration sites have taken place, disrupting the structure of
the ITR-flanked DNA without interfering with the expression
of both genes.
The observation that rep-mediated site-specific integration
in 293 cells is accompanied by rearrangements of the integra-
tion site and, possibly, of the inserted transgene cassette is not
unprecedented (5). Thus, it is not surprising that rearrange-
ment of the aavs1 region is detected upon infection of 293 cells
with Bac-ITR/RepA and subsequent selection of Hygr clones.
Although the biological reasons for such rearrangements are
not clear, it is important to point out that such genome rear-
rangements have been mostly documented with established
cell lines. It would be of interest to determine whether the
same rearrangements are detected in primary cultures. None-
theless, this result indicates that integration is not limited by
the size of the DNA flanked by the AAV terminal repeats and
can occur with DNA segments larger than the wild-type AAV
genome. Important large genes (such as the dystrophin gene)
can, at least in theory, be transduced and integrated by using
this system.
rep-mediated integration also occurs in the human fibroblast
cell strain MRC-5 after Bac-ITR/RepA infection. This conclu-
sion is based on the PCR amplification of the ITR-aavs1 junc-
tion that localizes the insertion of the ITR-flanked DNA cas-
sette in the same region of aavs1 as described previously for
AAV (40) (Fig. 9). Thus, although no further work has been
carried out to characterize the structure of the inserted DNA
or to determine the efficiency of site-specific integration, this
result extends the use of the hybrid Bac-AAV virus to human
diploid cells. The ITR-aavs1 junctions of the infected MRC-5
cells show similarities to those generated by wild-type AAV. In
fact, as previously reported (40), several nucleotides are found
in common between the ITR and aavs1 at the viral-cellular
junction (Fig. 9). In contrast, the insertion of a short stretch of
nucleotides in between the ITR-cellular junction was detected
in two junctions derived from strain 293 infected cells. The
mechanism by which these insertions have been generated is
not clear, but it is unlikely that they are artifacts of PCR am-
plification since the longer insertion shows 90-nucleotide se-
quence identity to a similar sequence reported by Samulsky
and coworkers (40). We have observed similar insertions in
Huh-7 cells infected with wild-type AAV (37). Although the bi-
ological significance of these insertions is not clear, it may be
related to differences between the diploid cell strain MRC-5
and the polyploid cell lines Huh-7 and 293.
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The results presented in this work indicate that transgene
excision from a double-stranded DNA baculovirus backbone
vector and subsequent integration into the human genome
occur with significant frequency. Thus, this study can be con-
sidered an important step towards improving the use of bacu-
lovirus as a vector for gene transfer since it demonstrates the
feasibility of using hybrid Bac-AAV virus for in vitro gene trans-
fer in human cells. Baculovirus infection in vivo, like retrovirus
infection, is hampered by serum components, namely, by com-
plement factors (41). Therefore, the use of this system may be
limited to ex vivo gene delivery. However, the data presented
here indicate that baculovirus infection and permanent trans-
duction of the target cells is not limited to hepatic cells. The
demonstration that hybrid viral vectors carrying specific ge-
netic elements of the AAV virus can direct integration of a
selected DNA sequence is an important starting point for the
construction of chimeric viral vectors suitable for in vivo gene
delivery.
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